SOMATIX ANNOUNCES APPOINTMENT OF ONCOLOGIST
SOMATIX ANNOUNCES APPOINTMENT OF ONCOLOGIST ALAMEDA, Calif., July 17 /PRNewswire/ -- Somatix Therapy Corp.
(NASDAQ: SOMA) today announced that Albert H. Owens, Jr., M.D. has joined the company as director of oncology and infectious diseases. In this new position, Owens will be responsible for the company's cancer program, and serve as the clinical liaison for human trials.
Owens, a professor at The Johns Hopkins University School of Medicine, was most recently director of the oncology center at that institution, and previously, president of The Johns Hopkins Hospital. He has participated in numerous cancer research committees including a term as the president of the Association of American Cancer Institutes and chairman of the National Coalition for Cancer Research. He is a trustee of the Johns Hopkins Hospital and a member of the boards of the Baltimore Life Insurance Co. and Optimedx, a privately held company. "Dr. Owens brings a wealth of cancer research experience to Somatix," stated David W. Carter, the company's chief executive officer. "He is a highly respected clinician and administrator. Owens will be instrumental in successfully taking the company's cancer program from the research laboratory into the clinic." Somatix Therapy Corp. is a scientific leader in the emerging field of gene therapy. The company is focused on the genetic modification of selected human cells to enable the production and delivery of therapeutic substances within the patient's body. Somatix believes that gene therapy, which requires gene transfer technology, will provide a safe and effective means of delivering many therapeutic substances. Somatix has gene therapy programs in cancer, central nervous system diseases and hemophilia. -0- 7/17/92 /CONTACT: Julie Wood of Somatix Therapy, 510-748-3082/ (SOMA) CO: Somatix Therapy Corp. ST: California IN: MTC SU: PER
JL -- SF003 -- 0266 07/17/92 12:55 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 17, 1992|
|Previous Article:||NEWBRIDGE-SUPPLIED TELECOM DENMARK FRAME RELAY FIELD TRIAL NETWORK GOES INTO SERVICE|
|Next Article:||FIRST OF MICHIGAN CAPITAL CORPORATION REPORTS INCREASED EARNINGS FOR THIRD QUARTER|